Rhein inhibits endometriosis by targeting microRNA-135

  • Wang Dan Department of Obstetrics and Gynecology, Wuhan Third Hospital-Tongren Hospital of Wuhan University, Wuhan, 430060, China
  • Zhang En Jing Department of Obstetrics and Gynecology, Wuhan Third Hospital-Tongren Hospital of Wuhan University, Wuhan, 430060, China
  • Jiang Juan Department of Obstetrics and Gynecology, Wuhan Third Hospital-Tongren Hospital of Wuhan University, Wuhan, 430060, China
  • Yang Yi Department of Obstetrics and Gynecology, Wuhan Third Hospital-Tongren Hospital of Wuhan University, Wuhan, 430060, China
  • Jiang Yi Ling Department of Obstetrics and Gynecology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, 430015, China
DOI: https://doi.org/10.18388/abp.2020_5935

Abstract

Endometriosis is a serious human gynecological disorder of women of reproductive age. The present study was designed to explore the therapeutic implications of rhein in the management of endometriosis. The results showed that rhein significantly (p<0.05) inhibited the proliferation of endometrial stroma cells in a dose-dependent fashion. Besides, the rhein treated endometrial stroma cells showed significantly (p<0.05) lower migration and invasion, in vitro. Transwell and wound healing assays showed that rhein also suppressed the migration and invasion of the endometrial stroma cells. Rhein was shown to target miR-135 at the molecular level to exert its anti-proliferative effects against the human endometrial stroma cells. Conversely, overexpression of miR-135 could nullify the anti-proliferative effects of rhein. Taken together, the findings of the present study highlight the therapeutic utility of rhein against human endometriosis. However, more in vivo studies are required.

Published
2022-08-31
Issue
Vol. 69 No. 3 (2022)
Section
Articles

Acta Biochimica Polonica is an OpenAccess quarterly and publishes four issues a year. All contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Copyright for all published papers © stays with the authors.

Copyright for the journal: © Polish Biochemical Society.